ORAL MEDICATIONS IN PATIENTS SUFFERING FROM ACUTE LOW BACK PAIN- NARRATIVE REVIEW

Authors

  • Dr. Shrut Vasavada
  • Dr. Nitin Samal
  • Dr. Devank Lohiya
  • Dr. Parth Shah

DOI:

https://doi.org/10.47750/pnr.2022.13.S05.47

Keywords:

Amphetamines, Atypical Opioids, Low Back Pain, NSAIDs, Opioids, Oral Medications

Abstract

Low back pain, whether with or without sciatica, is usually self-limiting and does not indicate a major underlying
condition. Reassurance, pain medicines, and encouragement to stay active are usually enough for most people. In some
patients, "red flag" abnormalities linked to an elevated risk of cauda equina syndrome, malignancy, infection, or fracture
necessitate a more thorough examination. These patients will also require more frequent monitoring and, in certain
situations, an immediate referral to a surgeon. Imaging can be postponed for at least four to six weeks in individuals with
nonspecific mechanical low back pain, allowing the discomfort to subside. Acetaminophen, nonsteroidal antiinflammatory medications, skeletal muscle relaxants to stay active have all been shown to be useful. When compared to
sham therapy, spinal manipulation therapy may produce short-term improvements, but not when compared to standard
treatments. The natural history of back pain, its overall favorable prognosis, and treatment suggestions should be the
emphasis of patient education.

Downloads

Published

2022-10-15

Issue

Section

Articles

How to Cite

ORAL MEDICATIONS IN PATIENTS SUFFERING FROM ACUTE LOW BACK PAIN- NARRATIVE REVIEW. (2022). Journal of Pharmaceutical Negative Results, 13, 329-332. https://doi.org/10.47750/pnr.2022.13.S05.47